🇺🇸 FDA
Patent

US 8445696

Synthetic methods for spiro-oxindole compounds

granted A61PA61P25/00A61P25/04

Quick answer

US patent 8445696 (Synthetic methods for spiro-oxindole compounds) held by Xenon Pharmaceuticals Inc. expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue May 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61P, A61P25/00, A61P25/04